New Horizon Health Ltd
HKEX:6606
Intrinsic Value
New Horizon Health Ltd. operates as an investment holding company. [ Read More ]
The intrinsic value of one
New Horizon Health Ltd
stock under the Base Case scenario is
29.1
HKD.
Compared to the current market price of 14.14 HKD,
New Horizon Health Ltd
is
Undervalued by 51%.
New Horizon Health Ltd's market capitalization is 6.5B HKD.
New Horizon Health Ltd stock price is 14.14 HKD.
New Horizon Health Ltd stock price (14.14 HKD) is 51% less than its Intrinsic Value (29.1 HKD).
New Horizon Health Ltd stock price (14.14 HKD) is 46% less than its DCF Value (26.18 HKD). Open DCF Valuation
New Horizon Health Ltd stock price (14.14 HKD) is 56% less than its Relative Value (32.01 HKD). Open Relative Valuation
New Horizon Health Ltd has upside potential of 245% compared to the average analyst price target.
Open Wall St Estimates
New Horizon Health Ltd's ROE (Return on Equity) for the past 12 months is very low and is equal to 4%.
New Horizon Health Ltd's Revenue has grown by an exceptional 245% over the past 12 months.
New Horizon Health Ltd's ROE (Return on Equity) has significantly decreased in the last 3 years from 72% to 4%.
New Horizon Health Ltd's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -317% to 369%.
New Horizon Health Ltd has negative Operating Income for the last twelve months.
New Horizon Health Ltd has positive Net Income for the last twelve months.
New Horizon Health Ltd's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 369%.
New Horizon Health Ltd has positive Gross Profit for the last twelve months.
New Horizon Health Ltd's Revenue is forecast to grow at a rate of 79% per year over the next 3 years.
New Horizon Health Ltd has negative Free Cash Flow for the last twelve months.
New Horizon Health Ltd's D/E (Debt to Equity) is very low and is equal to 0.14.
New Horizon Health Ltd has negative Net Debt. This means that the company has more cash and short-term investments (2B CNY) than debt (424m CNY).
New Horizon Health Ltd has negative three-year average ROE (Return on Equity): -140%. The company is not efficient at transforming stockholders' equity into net income.
New Horizon Health Ltd has negative three-year average ROIC (Return on Invested Capital): -315%. The company is not efficient at using invested capital to generate operating income.
New Horizon Health Ltd's short-term assets (3B CNY) exceed its short-term liabilties (265m CNY).
New Horizon Health Ltd's long-term assets (4B CNY) exceed its long-term liabilties (690m CNY).
New Horizon Health Ltd's Altman Z-Score is very high and is equal to 9.9.
New Horizon Health Ltd doesn't generate enough operating income (-109m CNY) to safely cover interest payments on its debt (7m CNY).
Valuation Backtest
New Horizon Health Ltd
Run backtest to discover the historical profit from buying and selling
New Horizon Health Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
New Horizon Health Ltd
Balance Sheet Decomposition
New Horizon Health Ltd
| Current Assets | 2.9B |
| Cash & Short-Term Investments | 1.7B |
| Receivables | 1B |
| Other Current Assets | 165.1m |
| Non-Current Assets | 817.3m |
| Long-Term Investments | 192m |
| PP&E | 199.9m |
| Intangibles | 25m |
| Other Non-Current Assets | 400.4m |
| Current Liabilities | 265.5m |
| Accounts Payable | 104.3m |
| Accrued Liabilities | 58.3m |
| Other Current Liabilities | 102.8m |
| Non-Current Liabilities | 424.1m |
| Long-Term Debt | 424.1m |
Earnings Waterfall
New Horizon Health Ltd
|
Revenue
|
1.4B
CNY
|
|
Cost of Revenue
|
-153.4m
CNY
|
|
Gross Profit
|
1.2B
CNY
|
|
Operating Expenses
|
-1.3B
CNY
|
|
Operating Income
|
-109.2m
CNY
|
|
Other Expenses
|
219.8m
CNY
|
|
Net Income
|
110.6m
CNY
|
Free Cash Flow Analysis
New Horizon Health Ltd
Profitability Score
Profitability Due Diligence
New Horizon Health Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Score
New Horizon Health Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
New Horizon Health Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
New Horizon Health Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
New Horizon Health Ltd
According to Wall Street analysts, the average 1-year price target for
New Horizon Health Ltd
is 48.8 HKD
with a low forecast of 22.22 HKD and a high forecast of 68.94 HKD.
Shareholder Return
Price
New Horizon Health Ltd
| Average Annual Return | -39.7% |
| Standard Deviation of Annual Returns | 51.61% |
| Max Drawdown | -85% |
| Market Capitalization | 6.5B HKD |
| Shares Outstanding | 457 601 460 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
New Horizon Health Ltd
Country
Industry
Market Cap
Dividend Yield
Description
New Horizon Health Ltd. operates as an investment holding company. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-02-18. The firm distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. The Company’s Youyou Tube (a stool-based self-checking gastric cancer screening test) and CerviClear (a non-invasive urine cervical cancer home screening test) are under development.
Contact
IPO
Employees
Officers
The intrinsic value of one
New Horizon Health Ltd
stock under the Base Case scenario is
29.1
HKD.
Compared to the current market price of 14.14 HKD,
New Horizon Health Ltd
is
Undervalued by 51%.
You don't have any saved screeners yet
